Mad In America
Science, Psychiatry, and Social Justice
News, Blogs, and Advocacy
http://madinamerica.com Keep comments civil. Honor differing viewpoints.
The site is designed to serve as a resource and a community for those interested in rethinking psychiatric care in the United States and abroad. We want to provide readers with news, personal stories, access to source documents, and the informed writings of bloggers that will further this enterprise. The bloggers on this site include people with lived experience, peer specialists, psychiatrists, psychologists, social workers, program managers, social activists, attorneys, and journalists. While their opinions naturally vary, they share a belief that our current system of psychiatric care needs to be vastly improved, and, many would argue, transformed. We welcome feedback and op-ed submissions from our readers.
–Robert Whitaker
********************************
Community Standards
At Mad in America, we are committed to maintaining a space for dialogue about rethinking psychiatric care that is rich with a diversity of voices and experiences. For this reason, we have an in-depth comment moderation policy on our website (see here: https://www.madinamerica.com/posting-guidelines/). We realize that many conversations happen off our website and occur in comments on our page. Consistent with best practices for non-profit social media management, we are now actively extending our commitment to moderate discussion occurring on our page. This means that comments on Facebook posts by and on our page will now be deleted or hidden if they are not consistent with our posting guidelines. In particular, we will, to the best of our ability, remove all forms of hate speech that make disparaging assertions based on a person’s identities or occupation, and calls for violence against any people. *Comments violating hate speech policies will be immediately deleted and user may be banned.*
When commenting on Mad in America's page please keep these guidelines in mind. This includes refraining from posting personal attacks, threats, spamming, misrepresentations of oneself or others, illegal material, profanity, hate speech, disparaging assertions about a person’s character, discrimination based on a person’s identity or occupation, and calls for violence against any people. We ask for good faith and the benefit of the doubt in our effort to allow anybody who wants to join the dialogue to do so without fear of abuse. Please respond to and criticize ideas, not character. This website intentionally brings together individuals with varying backgrounds and values. We believe civil, inclusive dialogue to be crucial to finding solutions to our current paradigm of mental health care. Remain relevant to the present article/topic. Off-topic comments are disruptive and derail the discussion. These may be removed by the moderator. Please see https://www.madinamerica.com/posting-guidelines/ for all guidelines.
10/05/2026
Song of the Week: Paranoid by Issa Ibrahim
“Paranoid” came about while looking in the mirror while hospitalized and medicated, finally catching a glimmer of the illness that I’d been denying was there. In that momentary gaze I saw myself and became critical of myself and wondered what others thought of me, suddenly feeling that it was the world looking at me through my self-deprecating eyes, projecting everyone’s hatreds and problems that they have with me, on me, through me. Struck by this multifoliate mind game, I declared, “I’m Paranoid,” then sat down to write the song.”
Link in the comments.
10/05/2026
Featured Artwork: The Journey by Alemayehu Darsema
From Alemayehu: The artwork titled "The Journey," which I created as part of my Bachelor of Fine Arts graduation project, embodies the Healing Phase of personal transformation. The deliberate transition from dark greens to lighter hues symbolizes the journey from despair toward hope, capturing the essence of exploration and acceptance in healing.
Art gallery link in the comments.
10/04/2026
Poem of the Week: A War Song to the Person Who Told Me to Die by Raine Ajani
Raine Ajani is a young student of the writing craft based in Portland, Oregon who hungers for growth. The daughter of an Ethiopian immigrant, she enjoys fantasy books, making jewelry, and exploring the nuances of the human experience through language and conversation.
Link to the full poem in the comments.
10/03/2026
Getting Rid of the Pain Before Answering Its Questions: Psychiatry’s Damage to Self and Culture
By Bruce Levine, PhD
Had psychiatric treatment been more successful in getting rid of pain before its questions were answered, the struggle for authentic self and a healing culture could well have been lost; as it is, those of us who care about such are only losing the struggle, but we have not been completely defeated.
Link in comments.
10/03/2026
From Mad in Italy: Before the era of modern psychiatric drugs, manic-depressive illness (the forerunner of "bipolar disorder") had an episodic natural history, with long periods of full recovery, low chronicity, and limited disability (Angst & Sellaro, 2000; Journal of Affective Disorders, 2009). Whitaker documents that its transformation into a chronic, recurrent, and highly disabling condition coincides with the introduction and spread of antidepressants, antipsychotics, and mood stabilizers (Whitaker, 2010).
10/02/2026
From Mad in Greece: Manolis Nanouris’s Good Omen (2026) is a short novella from Kypseli Publications about involuntary psychiatric hospitalization. Above all, though, it is about how power is organized, how it imposes itself on the individual, and how it shapes that person’s identity. The book does not simply follow the protagonist’s entry into a closed institution where others make decisions for him. It traces his gradual shift from person to patient: from someone who is able to speak to someone whose words are turned into part of his symptomatology. The author’s first-person narration keeps us constantly close to the protagonist and his experience, through his daily life in the clinic, his relationships with others, and the way he perceives what is happening.
10/02/2026
Fear, Mistrust, and Harm in Police-Involved Mental Health Crises
By Richard Sears
Studies highlight patient and community concerns about police responses alongside gaps in training, communication, and crisis alternatives.
Link in comments.
10/01/2026
Meeting Persephone: A Katabasis of Bipolar Night
by Forrest Wolfe
Persephone, the dark queen whose memory must never die. No longer the woman I met, but a deeper metaphysical image of descent, metamorphosis and return. To use Simone Weil’s term, this descent “de-creates” me. I am undone and unwound. Only through this unmaking is my return to life possible.
Link in the comments.
09/30/2026
From Efficacy to Non-Efficacy: Lessons from Pediatric Fluoxetine Trials
By Martin Plöderl, PhD
Fluoxetine is recommended as a first-line antidepressant to treat pediatric depression in major guidelines, and it is one of the most widely prescribed antidepressants for children and adolescents. However, modern studies find that fluoxetine has lost its efficacy and can now be considered clinically equivalent to placebo. In this piece, I will explain this puzzling phenomenon, which is also crucial for judging the efficacy of other common antidepressants. This issue has not yet been adequately addressed, which can lead to potential harm for young patients.
Link in comments.
09/30/2026
The VA’s New Prescribing Safety Reforms Are a Start – Here’s What’s Still Missing
By Derek Blumke
After months of pressure from more than 30 veterans organizations and Congress, the VA will require written informed consent before prescribing high-risk psychiatric medications — but the reforms stop short of what the data, and the coalition, are asking for.
Link in comments.
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
Cambridge, MA
02139
Alerts
Be the first to know and let us send you an email when Mad In America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.